Faculty, Staff and Student Publications
Language
English
Publication Date
4-1-2023
Journal
Radiology
DOI
10.1148/radiol.221109
PMID
36511808
PMCID
PMC10068886
PubMedCentral® Posted Date
12-13-2022
PubMedCentral® Full Text Version
Post-print
Abstract
Background
CT is the standard method used to assess bronchiectasis. A higher airway-to-artery diameter ratio (AAR) is typically used to identify enlarged bronchi and bronchiectasis; however, current imaging methods are limited in assessing the extent of this metric in CT scans.
Purpose
To determine the extent of AARs using an artificial intelligence–based chest CT and assess the association of AARs with exacerbations over time.
Materials and Methods
In a secondary analysis of ever-smokers from the prospective, observational, multicenter COPDGene study, AARs were quantified using an artificial intelligence tool. The percentage of airways with AAR greater than 1 (a measure of airway dilatation) in each participant on chest CT scans was determined. Pulmonary exacerbations were prospectively determined through biannual follow-up (from July 2009 to September 2021). Multivariable zero-inflated regression models were used to assess the association between the percentage of airways with AAR greater than 1 and the total number of pulmonary exacerbations over follow-up. Covariates included demographics, lung function, and conventional CT parameters.
Results
Among 4192 participants (median age, 59 years; IQR, 52–67 years; 1878 men [45%]), 1834 had chronic obstructive pulmonary disease (COPD). During a 10-year follow-up and in adjusted models, the percentage of airways with AARs greater than 1 (quartile 4 vs 1) was associated with a higher total number of exacerbations (risk ratio [RR], 1.08; 95% CI: 1.02, 1.15; P = .01). In participants meeting clinical and imaging criteria of bronchiectasis (ie, clinical manifestations with ≥3% of AARs >1) versus those who did not, the RR was 1.37 (95% CI: 1.31, 1.43; P < .001). Among participants with COPD, the corresponding RRs were 1.10 (95% CI: 1.02, 1.18; P = .02) and 1.32 (95% CI: 1.26, 1.39; P < .001), respectively.
Conclusion
In ever-smokers with chronic obstructive pulmonary disease, artificial intelligence-based CT measures of bronchiectasis were associated with more exacerbations over time.
Keywords
Aged, Female, Humans, Male, Middle Aged, Artificial Intelligence, Bronchi, Bronchiectasis, Follow-Up Studies, Pulmonary Disease, Chronic Obstructive, Regression Analysis, Smokers, Tomography, Emission-Computed, Cohort Studies
Published Open-Access
yes
Recommended Citation
Díaz, Alejandro A; Nardelli, Pietro; Wang, Wei; et al., "Artificial Intelligence-based CT Assessment of Bronchiectasis: The COPDGene Study" (2023). Faculty, Staff and Student Publications. 6712.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/6712
Graphical Abstract
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Phenomena Commons, Medical Genetics Commons, Oncology Commons
Comments
Clinical trial registration no. NCT00608764